Lv11
40 积分 2023-10-12 加入
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
4小时前
待确认
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
1个月前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
3个月前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
7个月前
已完结
Brain metastasis
8个月前
已完结
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report
11个月前
已完结
皖公网安备34019202002308
